+ 1-888-961-4454 | US : Int'l : + 91 (788) 802-9103 | support@researchdive.com
The global contract development and manufacturing organization market registered a revenue of nearly $126.9 billion in 2018 and is anticipated to grow at a 12.4% CAGR, surpassing $315.7 billion by 2026.
The market has witnessed positive growth rate in the forecast period. With the pandemic situation the contract development and manufacturing organization has witnessed growth. Many larger manufacturing units hire contract development and manufacturing organizations for production to sustain the business in the long run. Many companies have relied on contract development and manufacturing organization, which it is predicted to boost the contract development and manufacturing organization market in the forecast period.
| CAGR Pre COVID-19 | 9.8% |
| CAGR Post COVID-19 | 12.4% |
| Recovery By | |
| Realtime BPS | 260 |
| *Estimated market Size, 2020, Pre COVID | USD 152.2 Billion |
| **Real Time market Size, 2020, Post COVID | USD 178.9 Billion |
* The numbers are estimated prior to the COVID-19 Pandemic in 2020
** The data will vary depending on upcoming developments announced by the operating players
Contract development and manufacturing organization is an organization that works on contractual basis for specific companies to manage and organize the company’s duties, functions, and trials. The increasing demand in the pharmaceutical products due to the increase in the chronic diseases and geriatric population is predicted to boost the market in the forecast period. Most pharmaceutical industries have been contracting the contract development and manufacturing organizations, which is predicted to drive the market in the forecast period.
The unstructured way of working in these organizations is predicted to be the biggest restraint for the market in the forecast period. Moreover, in pharmaceutical industry a formal agreement is made with the other manufacturing firm for its development of various drugs. In case the manufacturing is in other company then the trade policies between the countries for exchanging drugs and other essential elements for manufacturing a new drug across nations is predicted to hinder the market growth in the forecast period.
The global contract development and manufacturing organization has witnessed a positive growth rate in the forecast period. Moreover, the pandemic situation is testing supply chain contingency plan throughout the industry and some of the manufacturing brands are proactively ordering or increasing the inventory with the help pf government officials, which will eventually boost the CDMO market in the forecast period.
The pharmaceutical industry is also facing a huge loss due to the lockdown. Once the lockdown is lifted many organizations might resort to CDMO to increase the efficiency. For instance, one of the major electronics giant Samsung Electronics Co., has minimized the potential effect of corona virus and declared to move its smartphone production from South Korea to Vietnam with the major CDMOs due to the spread of corona virus in the South Korea region.
The increasing demand from the end user to get the work done at a faster rate, many large companies hire contract development and manufacturing organizations to align the work in an appropriate manner. Increasing demand from the end user to organize, align the function make trial and perform duties is predicted to be the major driving factor for the contract development and manufacturing organization market.
Moreover, smaller contract development and manufacturing organizations have created a chaos in the market due to which the quality of the work is not delivered, which is predicted to be the major restraint for the market in the forecast period. Strategic collaboration and rising investment is predicted to create a huge opportunity in the contract development and manufacturing organization market in the forecast period. In addition, increasing demand for cell and gene therapies and increasing outsourcing of clinical trait to emerging market is predicted to create huge opportunities for the market.
Our group of skilled analysts provide a solution to help the companies to survive and sustain in this global pandemic. We support companies to make informed decisions based on our findings resulting from the comprehensive study by our qualified team of experts. Our study helps to acquire the following:
We'll help you fight this crisis through our business intelligence solutions.